The clinical use of benzodiazepines (BZs) is hampered by sedation and cognitive deterioration. Although genetic and pharmacological studies suggest that a 1 -and a 5 -containing GABA A receptors mediate and/or modulate these effects, their molecular substrate is not fully elucidated. By the use of two selective ligands : the a 1 -subunit affinity-selective antagonist b-CCt, and the a 5 -subunit affinity-and efficacyselective antagonist XLi093, we examined the mechanisms of behavioural effects of diazepam in the tests of spontaneous locomotor activity and water-maze acquisition and recall, the two paradigms indicative of sedative-and cognition-impairing effects of BZs, respectively. The locomotor-activity decreasing propensity of diazepam (significant at 1.5 and 5 mg/kg) was antagonized by b-CCt (5 and 15 mg/kg), while it tended to be potentiated by XLi093 in doses of 10 mg/kg, and especially 20 mg/kg. Diazepam decreased acquisition and recall in the water maze, with a minimum effective dose of 1.5 mg/kg. Both antagonists reversed the thigmotaxis induced by 2 mg/kg diazepam throughout the test, suggesting that both GABA A receptor subtypes participate in BZ effects on the procedural component of the task. Diazepam-induced impairment in the declarative component of the task, as assessed by path efficiency, the latency and distance before finding the platform across acquisition trials, and also by the spatial parameters in the probe trial, was partially prevented by both, 15 mg/kg b-CCt and 10 mg/kg XLi093. Combining a BZ with b-CCt results in the near to control level of performance of a cognitive task, without sedation, and may be worth testing on human subjects.
Introduction
All benzodiazepines (BZs) currently in clinical practice act as positive modulators of fast inhibitory neurotransmission mediated through those populations of GABA A receptors which contain a 1 , a 2 , a 3 or a 5 subunits in addition to the c 2 subunit (y80 % of all GABA A receptors). The diverse pharmacological effects of BZs : anxiolytic, sedative, hypnotic, muscle relaxant, anticonvulsive and amnesic, stem from the substantial involvement of GABA A receptors in the regulation of vigilance, anxiety, muscle tension, epileptogenic activity, and memory functions Sieghart & Ernst, 2005) .
Although very effective in short-term treatment of different psychiatric and neurological ailments (mostly anxiety disorders, insomnia, muscle spasms and epilepsy), BZs are not free of psychomotor and cognitive impairing effects, those prominent being sedation and anterograde amnesia (Lader, 1999) . Sedation is basically related to suppression of the unconditioned psychomotor performance. Sometimes, the effect seen after use of certain doses of BZs is an increase, not a decrease of the tracked activity, the most parsimonious explanation of this phenomenon being related to the disinhibitory properties of BZs (Crawley, 1985) . On the other hand, the specific cognitive effect of BZs appears to be more an impairment of learning (acquisition) than an effect on memory (retention) itself, and the term 'acquisition impairing' would be more appropriate than 'amnesic ' (Clement & Chapouthier, 1998) .
Based on pharmacological studies with ligands with some degree of GABA A receptor subtype selectivity, such as CL218,872 and zolpidem (e.g. Depoortere et al. 1986 ; Lippa et al. 1979) , it has been hypothesized that the four populations of BZ-binding site-containing GABA A receptors, with their distinct patterns of anatomical distribution in the mammalian brain, may represent differentiable molecular substrates for the various effects of BZs. The recent genetic studies with mice carrying a point mutation ('knock-in ') of histidine to arginine in a 1 , a 2 , a 3 or a 5 subunits, rendering the respective GABA A receptors selectively insensitive to effects of BZs, substantiated the possibility of a specific contribution of individual receptor subtypes to the spectrum of behavioural actions of the reference BZ, diazepam (reviewed in , 2006 . The plausibility of selective switching off of, for clinical use, mainly unwanted sedative-and acquisition-impairing effects of BZs is highly desirable, and demands additional knowledge of the molecular and cellular substrates of these effects. Experimental evidence to date, including the screening of newer affinity-and/or efficacy-selective BZ site ligands, suggests that GABA A receptors containing a 1 and a 5 subunits may be of importance in exerting these two effects in mutated and wild-type animals Rudolph et al. 1999 ; Savić et al. 2008a ; van Rijnsoever et al. 2004) . Without questioning the main contribution of the a 1 subunit , Rudolph et al. 1999 , experiments with ligands functionally selective for a 2 -, a 3 -and a 5 -, or essentially selective for a 5 -containing subtypes of GABA A receptors, suggest that sedation may be partly dependent on activity mediated by a 5 -containing GABA A receptors (Savić et al. 2008a) . Moreover, based on inhibitory (Savić et al. 2008a, b) or excitatory (Hauser et al. 2005 ; van Rijnsoever et al. 2004 ) influences of modulation of activity exerted by neurons expressing the a 5 -subunitcontaining GABA A receptors on locomotor output, existence of certain discontinuous ' effective windows ' of this modulation, which could enable the 'on/off switch ' role of these receptors in control of vigilance, was proposed (Savić et al. 2008b) .
On the other hand, behavioural studies with subtype selective ligands (Savić et al. 2005a (Savić et al. , b, 2008b and genetically modified animals (Collinson et al. 2002 ; Crestani et al. 2002 ; Rudolph et al. 1999) have indicated that both, the a 1 -and a 5 -subunit-containing GABA A receptors, comprise the 'memory-modulating ' population of these receptors. It appears that the impairing effects of BZs on the acquisition of procedural memory, as assessed in the active avoidance paradigm, may predominantly depend on the a 1 -containing GABA A receptors (Savić et al. 2005b) , while the influence on the acquisition of declarative memory, assessed in the passive avoidance paradigm, probably involves the a 5 subunit, in addition to the a 1 subunit (Rudolph et al. 1999 ; Savić et al. 2005a) .
The aim of the present study was to elucidate, by the use of two selective ligands, the preferential a 1 -subunit affinity-selective antagonist b-CCt, and the a 5 -subunit affinity-and efficacy-selective antagonist XLi093, to what extent GABA A receptors containing a 1 and a 5 subunits contribute to the well-established behavioural effects of diazepam in the tests of spontaneous locomotor activity and water-maze acquisition and recall, the two paradigms mainly, but not exclusively, indicative of sedative-and spatialcognition-impairing effects of BZs, respectively. The selectivity of b-CCt and XLi093 has been confirmed in in-vitro experiments of affinity and efficacy at recombinant GABA A receptors (Huang et al. 2000 ; June et al. 2003 ; Li et al. 2003) , as well as in in-vivo studies of inhibition of [
3 H]flumazenil binding in distinct brain regions, which differ in the GABA A receptor subtype expression (Griebel et al. 1999 ; Shinday et al. 2008) . [1,4]benzodiazepine-3-carboxylic acid, 8-ethynyl-5,6-dihydro-5-methyl-6-oxo-, 1,3-propanediyl ester) , the a 5 -subunit affinity-and efficacy-selective antagonist, and b-CCt (t-butyl-bcarboline-3-carboxylate), the preferential a 1 -subunit affinity-selective antagonist were synthesized at the Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, as described in detail previously (Cox et al. 1995 ; Li et al. 2003) . Diazepam was obtained from Galenika (Serbia).
Materials and methods

Drugs
Belgrade. The rats were housed in transparent plastic cages, six animals per cage, and had free access to pelleted food and tap water. The temperature of the animal room was 22¡1 xC, relative humidity 40-70 %, illumination 120 lx, with a 12-h light/dark cycle (lights on 06:00 hours). All handling and testing took place during the light phase of the diurnal cycle. Separate groups of animals were used for two behavioural paradigms. The behaviour was recorded by a ceilingmounted camera and analysed by ANY-maze Video Tracking System software (Stoelting Co., USA). The drugs were dissolved/suspended with the aid of sonication in a solvent containing 85 % distilled water, 14 % propylene glycol, and 1 % Tween-80, and were administered in a total volume of 2 ml/kg, 20 min before behavioural testing. The first treatment indicated in combination was administered into the lower right quadrant of the peritoneum, and the second treatment immediately afterwards into the lower left quadrant of the peritoneum.
Measurement of locomotor activity
Twenty minutes after receiving the appropriate treatment, single rats were placed in a clear Plexiglas chamber (40r25r35 cm). Activity under dim red light (20 lx) was recorded for a total of 30 min, without any habituation period, using ANY-maze software. Besides the total distance travelled, behaviour was analysed by dividing the locomotor activity data into 5-min bins.
Two experiments were performed. In the first, the dose-response curve for diazepam (0, 0.5, 1.5, 5.0 mg/ kg) was determined. In the second experiment, the design included the factors agonist (the same doses of diazepam as those used in the dose-response study) and antagonists (b-CCt at 0, 5, 15 mg/kg, and XLi093 at 0, 10, 20 mg/kg), thus generating 20 experimental groups in total.
Behaviour in the Morris water maze
The water maze consisted of a black cylindrical pool (diameter 200 cm, height 60 cm), with a uniform inner surface. The pool was filled to a height of 30 cm with water at 23 xC (¡1 xC). The escape platform of black plastic (15r10 cm) was submerged 2 cm below the water surface. The platform was invisible to rats by being the same colour as the pool wall (Terry, 2000) . There were many distal cues in the testing room (doors, pipes on the walls and the ceiling, cupboards, a camera suspended above the centre of the maze). An indirect illumination in the experimental room was provided by white neon tubes fixed on the walls.
The rats received the appropriate treatment 20 min before a swimming block, each day for 5 consecutive days of spatial acquisition. Each block consisted of four trials, lasting a maximum time of 120 s, the intertrial interval being 60 s. For each trial the rat was placed in the water facing the pool at one of four pseudo-randomly determined starting positions. As during spatial learning the platform was hidden in the middle of the NE quadrant, the four distal start locations chosen were S, W, NW and SE (Fig. 1) . Once the rat found and mounted the escape platform it was permitted to remain on the platform for 15 s. The rat was guided to the platform by the experimenter if it failed to locate it within 120 s. To assess the long-term spatial memory at the end of learning, a probe trial for 60 s, with the platform omitted, was given 24 h after the last acquisition day. The probe trial, starting from the novel, most distant SW location (in order to ensure that any spatial bias is a consequence of the spatial memory of escape location, rather than of a specific swim strategy ; Vorhees & Williams, 2006) , was performed without any pre-treatment. A drug-free probe trial (cf. McNamara & Skelton, 1993) was chosen because diazepam impairs acquisition, but not retrieval of place preference in the water maze (Anand et al. 2007 ; McNamara & Skelton, 1991) , and confounding effects of possible sensorimotor, i.e. non-cognitive actions of treatment on recall performance were avoided by such a protocol. The tracking software virtually divided the pool into four quadrants, three concentric annuli and a target region consisting of the intersection of the platform quadrant and the platform annulus (Fig. 1) . Similar to the approach used by Cain (1997), the central annulus was set up to 10 % of the whole area ; the platform annulus equalled 40 %, whereas the area of the peripheral annulus was 50 % of the whole.
Dependent variables chosen for tracking during the acquisition trials were : latency to platform (time from start to goal), total distance swam (path length), average swim speed and path efficiency (the ratio of the shortest possible path length to actual path length). All these indices are, to a lesser or greater degree, related to goal-directed behaviour, i.e. spatial learning (Vorhees & Williams, 2006) . As thigmotaxis (the tendency to swim or float near the pool wall) represents a factor which accounts for much of the variance in the watermaze performance, and normally weakens during consecutive trials (Vorhees & Williams, 2006) , we quantified the persistence of thigmotaxis in the target (NE) quadrant. The loss of thigmotaxis is related to the procedural component of acquisition, and the percent of the distance swum in the target region (away from the wall) of the target quadrant may be seen as a measure of procedural learning.
The indices of memory, assessed during the probe trial, included the distance and time in the platform (target) quadrant, platform ring and target region, as well as the number of entries and distance swum in the area where the platform used to be during training ( Fig. 1 ). In addition, the distance swum during 60 s in the probe trial was taken as a measure of overall activity, while peripheral ring parameters (distance and time) were connected to thigmotaxic behaviour.
Three experiments in the water maze were performed. In the first, the dose-response curve for diazepam (0, 1, 1.5, 2, 5 mg/kg) was determined. In the second experiment, the influences of b-CCt (5, 15 mg/kg) and XLi093 (10, 20 mg/kg) on the effects of 1.5 mg/kg diazepam (the minimal effective dose from the dose-response study) were assessed. The inclusion of the groups treated by the antagonists without diazepam would have made the experiment overly long, on each of five training days. In preliminary experiments with the current protocol, we noticed the lack of behavioural activity of higher doses of b-CCt and XLi093 used here (15, 20 mg/kg, respectively). In the third water-maze experiment, we assessed the capability of b-CCt (15 mg/kg) and XLi093 (10 mg/kg) to antagonize the behavioural effects of a higher dose of diazepam (2 mg/kg).
Statistical analysis
All numerical data presented in the figures are given as the mean¡S.E.M. Data from the activity assay were assessed by a one-way or two-way ANOVA, whereas the results from the water-maze test were analysed using a two-way ANOVA with repeated measures. Post-hoc comparisons, where applicable, were performed using Student-Newman-Keuls or Dunnett's test. Statistical analyses were performed with ANYmaze Video Tracking System software (Stoelting Co., USA).
Results
Motor activity assay
An ANOVA showed a significant effect of diazepam treatment on total distance travelled during 30 min of monitoring [F(3, 28) =5.63, p=0.004] (Fig. 2a) . According to Dunnett's test, the activity-depressing effect of two higher doses of diazepam was significant compared with solvent control. When the analysis of travelled distance was developed into 5-min intervals ( Fig. 2 b) , it was seen that a dose of 5 mg/kg diazepam highly significantly decreased locomotion in the 0-15 min period, whereas a dose of 1.5 mg/kg was effective in the 20-25 min period. On the other hand, while devoid of discernible activity of their own ( (Fig. 3) . Namely, comparisons within the 10 mg/kg XLi093 level have shown highly significant differences in the effects of 1.5 and 5 mg/kg doses of diazepam vs. the effect of the antagonist itself (p=0.003 in both cases), whereas within the dose of 20 mg/kg XLi093, all three levels of diazepam (0.5, 1.5, 5 mg/kg) were statistically different from the antagonist (respective p values : 0.013, 0.002, <0.001). Similar conclusions can be reached while statistically analysing (not shown) the data obtained by dividing the locomotor activity into 5-min bins (Fig. 4) . As a rule, locomotor activity of animals treated with combination of diazepam+ b-CCt, irrespective of the dose employed, was near to, or slightly above, the control value, whereas XLi093, especially at the higher dose, tended to deepen, or unveil, the sedation induced by diazepam.
Morris water maze
For the dose-response study of diazepam, the factors treatment and days, as well as the interaction treatmentrdays, were statistically highly significant for the latency to find platform, the distance swum before finding the platform, swim speed and path efficiency ; significant differences among treatments during training days are presented in Fig. 5 . The results of the posthoc analysis for the factor treatment are summarized in Table 1 . The analysis showed that the lowest effective dose of diazepam was 1.5 mg/kg. The incapacitating influences of previous treatment with diazepam were also discernible during the probe trial (Table 2) , when a number of indices of memory (time in platform quadrant, time and distance in platform ring, time and distance in target region) were dose-dependently adversely affected. Concomitantly, a significant increase of peripheral ring parameters, i.e. pronounced thigmotaxis (Table 2) , has confirmed that learning the required water-maze skills and strategies was impaired under diazepam. Based on the presented dose-response study, we performed a further experiment in which two doses of each of the antagonists, tested in the locomotor activity assay, were combined with 1.5 mg/kg diazepam. However, in this experiment, the effect of diazepam did not reach significance compared with control, for any of the learning measures calculated. A two-way ANOVA with repeated measures for this antagonism study revealed significant variability in regard to latencies to find the platform [treatment effect : F(5, 138)=6.59, p<0.001 ; day effect : F(4, 552)=50.39, p<0.001 ; and treatmentrday interaction : F(20, 552)= 1.80, p=0.018] and path efficiencies across the 5 d [treatment effect : F(5, 138)=4.67, p=0.001 ; day effect : F(4, 552)=17.61, p<0.001 ; treatmentrday interaction : F(20, 552)=1.88, p=0.012]. The respective significant differences among treatments during days are presented in Fig. 6(a, d) . The factors, but not the interaction, also reached significance when swim distances (Fig. 6 b) and average swim speed (Fig. 6 c) were analysed [treatment effect : F(5, 138)=5.42, p<0.001 ; day effect : F(4, 552)=34.27, p<0.001 ; treatmentr day interaction : F(20, 552)=1.50, p=0.075 ; and treatment effect : F(5, 138)=5.02, p<0.001 ; day effect : F(4, 552)=21.08, p<0.001 ; treatmentrday interaction : F(20, 552)=1.22, p=0.233, respectively]. Bearing in mind especially the latency to platform (Fig. 6 a) , it appears that antagonism of the effects of diazepam at GABA A receptors containing a 5 subunits (1.5 mg/kg diazepam+10 mg/kg XLi093) may enhance acquisition in the earliest stages of spatial learning, while addition of a higher dose of the antagonist (1.5 mg/kg diazepam+20 mg/kg XLi093) may even impair the later phases of learning. Throughout the acquisition trials, there were no discernible effects of adding bCCt, at either dose, to diazepam. In the probe trial, the significant differences in dependent measures of performance were generally absent, probably due to the lack of clear behavioural activity of the used dose of diazepam, and these data are not presented.
Finally, the results of the experiment with a higher effective dose of diazepam (2 mg/kg), on its own and in combination with 10 mg/kg XLi093 and 15 mg/kg bCCt are shown in Figs 7 and 8, and Tables 3 and 4. A two-way ANOVA with repeated measures of latencies to find the platform across the 5 d (Fig. 7 a) revealed the following results [treatment effect : F(3, 100)=11.65, p<0.001 ; day effect : F(4, 400)=56.74, p<0.001 ; treatmentrday interaction : F(12, 400)=0.96, p=0.484]. Similar tendencies were evident when swim distances (Fig. 7 b) and path efficiencies (Fig. 7 d) were analysed [treatment effect : F(3, 100)=6.34, p=0.001 ; day effect : F(4, 400)=28.17, p<0.001 ; treatmentrday interaction : F(12, 400)=1.46, p=0.135 ; and treatment effect : F(3, 100)=5.98, p=0.001 ; day effect : F(4, 400)=27.68, p<0.001 ; treatmentrday interaction : F(12, 400)=1.03, p=0.422, respectively]. The interaction only reached significance when swim speed was analysed [treatment effect : F(3, 100)=6.29, p=0.001 ; day effect : F(4, 400)=14.03, p<0.001 ; treatmentrday interaction : F(12, 400)=1.92, p=0.031], and significant differences among treatments during days are given in Fig. 7c . As treatment as a factor was statistically significant for all four learning parameters illustrated, the respective significances for single treatments are shown in the Table 2 . bCCt (15 mg/kg) completely prevented acquisition-impairing actions of diazepam administered at the dose of 2 mg/kg, whereas addition of XLi093 (10 mg/kg) was effective in this sense for all parameters considered, with the exception of the mean swim speed (Table 3) . It should be noted that statistical analysis revealed no overall significant difference in maximum speed in treatments ; moreover, on the first day, the rats treated with diazepam were even faster, in maximum, than control rats (1.16¡ 0.44 m/s vs. 0.78¡0.14 m/s), which is a hint of transient behavioural disinhibition.
In Fig. 8 , the distances the rats swam in the platform quadrant (NE) during acquisition trials are presented alongside the respective distance in the portion of NE quadrant lying in the platform annulus of the maze (' the target region'). The rats treated with 2 mg/kg diazepam strikingly lacked the preferential activity in that part of the NE quadrant in which platform finding was possible ; even on day 5, only 49.4 % of the distance they travelled in NE quadrant was in the target region ; the respective values for control, 2 mg/kg diazepam+15 mg/kg bCCt and 2 mg/kg diazepam+ 10 mg/kg XLi093 groups were 75.4 %, 82.9 % and 69.8 %.
In Table 4 , a number of parameters calculated from the probe trial performance in the antagonism study with 2 mg/kg diazepam are presented. The total distance swum was not different, and there were also no significant differences among groups regarding distance and time spent in the platform quadrant. On the other hand, animals treated for 5 d with diazepam exerted a strong bias towards the peripheral annulus, which was reversed by both antagonists. Concomitantly, previous treatment with diazepam resulted in significant avoidance of the platform annulus, which was also antagonized by both, bCCt (15 mg/kg) and XLi093 (10 mg/kg). The changes of these two parameters are indicative of influences on the previous days' behavioural strategies learning, i.e. the procedural component of water-maze spatial memory. There were no significant differences in target region activity, whereas diazepam treatment tended to decrease platform site entries and significantly decreased the distance in platform position. The latter effect, indicative of influence on the declarative spatial component of memory, was attenuated, but not reversed, by both antagonists.
Discussion
The a 1 -and a 5 -containing GABA A receptors have been repeatedly implicated, to a different degree, in mediation or modulation of widely known sedative and amnesic effects of agonists at BZ-sensitive GABA A receptors Rudolph et al. 1999 ; Savić et al. 2008 a ; van Rijnsoever et al. 2004 ). The present experiments, using the selective antagonists at BZ site of a 1 -and a 5 -containing GABA A receptors, demonstrated that the activity-decreasing propensity of diazepam, as a measure of sedation, is the consequence of its binding at a 1 -containing GABA A receptors, whereas spatial learning and memory deficits induced by diazepam are related to action at both of these receptor populations.
The findings in the motor activity assay on the predominant role of a 1 GABA A receptors are in accord with genetic studies Rudolph et al. 1999 ). What appears to be the most surprising result of this part of the study, combining diazepam with XLi093, especially with the higher (20 mg/kg) of the two tested doses of the antagonist, potentiated sedation induced by diazepam. The 20 mg/kg dose of XLi093 presumably caused a complete antagonism of effects of diazepam at a 5 -containing GABA A receptors (cf. occupancy of about 65 % of a 5 GABA A receptors in mice at 10 mg/kg XLi093 in Shinday et al. 2008) . We have recently put forward the hypothesis that locomotor-activity changes induced by ligands possessing a substantial a 5 efficacy may be, at least partly, contributed by modulation at GABA A receptors containing this subunit (Savić et al. 2008 a) . It appears that the role of positive modulation at a 5 GABA A receptors depends on the concomitant activity at a 1 -containing GABA A receptors. Moreover, a 5 GABA A receptors may exert a dual control on the state of vigilance : to limit sedative effects elicited by supraphysiological stimulation of a 1 -containing receptors, and, conversely, to enhance basal/endogenous activation of a 1 GABA A receptors, thereby inducing mild sedation. Three sets of data may indirectly support the notion of the modulatory role of this population of receptors. First, it is notable that a 5 -containing GABA A receptors are at least moderately present in both regions believed to be involved in the sedative properties of GABA A receptor activators (Hentschke et al. 2005 ; Kiehn, 2006) , i.e. ventral horn of the spinal cord (Bohlhalter et al. 1996) , and pyramidal neurons of the neocortex, especially layer V (Pirker et al. 2000 ; Yamada et al. 2007) . Second, there is a conspicuous association between a 1 and a 5 subunits : the co-localization within individual neurons (Bohlhalter et al. 1996) , and even within the single GABA A receptor (Araujo et al. 1999) . Third, the knock-in mice harbouring the a 5 subunit insensitive to diazepam are refractory to development of tolerance to the a 1 -mediated sedative effect of diazepam at subchronic doses (van Rijnsoever et al. 2004) . The effects of diazepam on the acquisition and retention of place learning in the water maze have been previously assessed in two settings, similar but not identical to the present procedure (Arolfo & Brioni, 1991 ; Cain, 1997) . The lowest dose effective in our experiment (1.5 mg/kg) lies between those found by Arolfo & Brioni (1.0 mg/kg) and Cain (3.0 mg/kg diazepam). However, the antagonism study showed that the 1.5 mg/kg dosage level was a borderline dose of diazepam, unreliable in affecting rats' behaviour under the conditions used in the current water-maze protocol. Nevertheless, in such settings, an impairment of the later phases of water-maze learning produced by the combination of diazepam (1.5 mg/ kg) and the higher dose of XLi093 (20 mg/kg) was revealed. We hypothesize that this finding may be connected with the profound sedation observed with the same combination in the procedure measuring locomotor activity. Namely, it is possible (cf. van Rijnsoever et al. 2004 ) that the supposed complete antagonism at a 5 -containing GABA A receptors forestalls development of tolerance to sedation and/or decreased vigilance, and hence impairs learning ; this question could be partly resolved with further studies of repeated dosing of diazepam and XLi093 in the locomotor activity test.
In the antagonism study with 2.0 mg/kg diazepam, both antagonists tended to reverse its effects, which may be seen as corroborating previous conclusions that the water-maze acquisition impairment is not due to the sedative effect of diazepam (McNamara & Skelton, 1991) . The fact that rats treated with the combination 2 mg/kg diazepam+15 mg/kg b-CCt were even faster swimmers, overall, than the group treated with diazepam and the group treated with the combination 2 mg/kg diazepam+10 mg/kg XLi093, replicates our previous finding with the combination of 2 mg/kg midazolam+30 mg/kg b-CCt, which potentiated inter-trial crossings during the acquisition session of active avoidance paradigm (Savić et al. 2005b) . In regard to the cognitive function-related parameters, b-CCt antagonized the inhibitory effect of midazolam on procedural memory tested through active avoidance retention (Savić et al. 2005b) , and attenuated the deteriorating effect of the BZ on declarative memory in passive avoidance paradigm (Savić et al. 2005a ). In the anxiety-related paradigms (elevated plus maze and acquisition session of active avoidance), potentiation of the anti-anxiety action of midazolam was observed (Savić et al. 2004 (Savić et al. , 2005b . As the emotionally arousing experiences tend to be well remembered (McGaugh, 2004) , it is widely accepted that suppression of arousal and anxiety by BZs may impair some aspects of cognitive functioning (Curran, 1991) . However, the present water maze results, together with the previous findings, dismiss the suggestion (Zanotti et al. 1994 ) that the diazepaminduced place learning impairment may be mainly related to its anxiolytic properties. Despite the fact that the anti-anxiety effect of diazepam may have only been preserved or potentiated, not abolished, by b-CCt, the overall performance during five acquisition days was at least equal to that of the control group. The present and previous results suggest that combining a BZ with b-CCt may result in a near to control level of performance of a cognitive task, without sedation, but with highly desirable preserved antianxiety activity.
On the other hand, Cain (1997) suggested that the acquisition deficits may result from the sensorimotor disturbances that diazepam causes. Namely, the author found that non-spatial pretraining without pretreatment eliminated swimming in the periphery of the pool, platform deflections and swimovers, and resulted in the normal, rapid acquisition of the watermaze task under diazepam (Cain, 1997) . Nevertheless, McNamara & Skelton (1991) found that treatment with diazepam after the rats acquired the location of the platform did not affect further water-maze activity, while it did impair finding of the newly located platform. Bearing in mind the interaction between arousal, cognitive function and anxiety (Curran, 1991) , it is difficult to say that the present results support the view of either pure learning-impairing (McNamara & Skelton, 1991) or non-selective incapacitating (Cain, 1997) effects of diazepam as the explanation for its 
